» Articles » PMID: 36845376

Role of LncRNAs in the Pathogenic Mechanism of Human Decreased Ovarian Reserve

Overview
Journal Front Genet
Date 2023 Feb 27
PMID 36845376
Authors
Affiliations
Soon will be listed here.
Abstract

Decreased ovarian reserve (DOR) is defined as a decrease in the quality and quantity of oocytes, which reduces ovarian endocrine function and female fertility. The impaired follicular development and accelerated follicle atresia lead to a decrease in the number of follicles, while the decline of oocyte quality is related to the disorder of DNA damage-repair, oxidative stress, and the dysfunction of mitochondria. Although the mechanism of DOR is still unclear, recent studies have found that long non-coding RNA (lncRNA) as a group of functional RNA molecules participate in the regulation of ovarian function, especially in the differentiation, proliferation and apoptosis of granulosa cells in the ovary. LncRNAs participate in the occurrence of DOR by affecting follicular development and atresia, the synthesis and secretion of ovarian hormones. This review summarizes current research on lncRNAs associated with DOR and reveals the potential underlying mechanisms. The present study suggests that lncRNAs could be considered as prognostic markers and treatment targets for DOR.

Citing Articles

FOXL2 interaction with different binding partners regulates the dynamics of ovarian development.

Migale R, Neumann M, Mitter R, Rafiee M, Wood S, Olsen J Sci Adv. 2024; 10(12):eadl0788.

PMID: 38517962 PMC: 10959415. DOI: 10.1126/sciadv.adl0788.


Bushen Huoxue formula for the treatment of diminished ovarian reserve: A combined metabolomics and integrated network pharmacology analysis.

Zeng P, Zhou H, Guo P, Han N, Zhang X, Yin Z Heliyon. 2023; 9(9):e20104.

PMID: 37809906 PMC: 10559866. DOI: 10.1016/j.heliyon.2023.e20104.

References
1.
Elizur S, Dratviman-Storobinsky O, Derech-Haim S, Lebovitz O, Dor J, Orvieto R . FMR6 may play a role in the pathogenesis of fragile X-associated premature ovarian insufficiency. Gynecol Endocrinol. 2015; 32(4):334-7. DOI: 10.3109/09513590.2015.1116508. View

2.
Elizur S, Friedman Gohas M, Dratviman-Storobinsky O, Cohen Y . Pathophysiology Mechanisms in Fragile-X Primary Ovarian Insufficiency. Methods Mol Biol. 2019; 1942:165-171. DOI: 10.1007/978-1-4939-9080-1_14. View

3.
Dixit H, Rao L, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N . Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet. 2006; 119(4):408-15. DOI: 10.1007/s00439-006-0150-0. View

4.
Li D, Wang X, Dang Y, Zhang X, Zhao S, Lu G . lncRNA is involved in premature ovarian insufficiency by regulating p27 translation in GCs via competitive binding to PTBP1. Mol Ther Nucleic Acids. 2020; 23:132-141. PMC: 7733005. DOI: 10.1016/j.omtn.2020.10.041. View

5.
Aldonza M, Hong J, Lee S . Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation. Exp Mol Med. 2017; 49(1):e286. PMC: 5291837. DOI: 10.1038/emm.2016.131. View